Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -982 | -3 | N/A | -21 | -19 |
| Depreciation Amortization | 284 | 0 | N/A | 0 | 0 |
| Accounts receivable | -197 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 3 | N/A | N/A | -1 |
| Other Working Capital | -25 | 3 | N/A | N/A | -1 |
| Other Operating Activity | 595 | -3 | 0 | 0 | 1 |
| Operating Cash Flow | $-325 | $0 | $N/A | $-20 | $-20 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-6 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 265 | 0 | N/A | N/A | N/A |
| Debt Repayment | -38 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 3 | N/A | 2 | N/A |
| Financing Cash Flow | $227 | $3 | $N/A | $2 | $N/A |
| Beginning Cash Position | 201 | 1 | N/A | 22 | 22 |
| End Cash Position | 98 | 4 | N/A | 3 | 2 |
| Net Cash Flow | $-104 | $3 | $N/A | $-19 | $-20 |
| Free Cash Flow | |||||
| Operating Cash Flow | -325 | 0 | N/A | -20 | -20 |
| Capital Expenditure | -6 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -331 | 0 | 0 | -20 | -20 |